Linda Sullivan
Clinical Trial Optimization
Good podcast? Give it some love!
Linda Sullivan
Clinical Trial OptimizationEpisodes
Linda Sullivan
Clinical Trial Optimization
Good podcast? Give it some love!
Rate Podcast
Episodes of Clinical Trial Optimization
Mark All
Search Episodes...
During the 2022 WCG MAGI Clinical Research Conferences in Boston and Las Vegas, Linda Sullivan invited attendees to stop by the CTO podcast booth and share their ideas about the top three things that the industry should do to improve how clinic
Hannah Reimer and Tara White at Temple University joined Linda Sullivan to discuss their collaboration to develop a systematic way of including researchers in the clinical care of patients. Faced with the challenge of not having patients eligib
Patricia Roselle, global head, patient stakeholder engagement at Sanofi ,joins Linda Sullivan to share insights about the success of an innovative model that directly and intentionally collaborates with patient advisors and advocacy groups fro
Have you ever had a resume come across your desk that looked too good to be true? You bring the candidate in for an interview where they say all the perfect things, only to hire them and find out they were nothing like they led you to believe?
Brandi Bratrude at Boston Children’s Hospital and Mona Li at the Dana Farber Cancer Institute joined Linda Sullivan to discuss a successful Intern-to-FTE pipeline program at the Boston Children’s Hospital. The program, made possible through a c
Is there a way for sponsors and clinical trial sites to donate unused lab kits and supplies for humanitarian aid? This is the question explored during Linda Sullivan’s interview with Mark Ryan vice president, head site management Americas regio
How are organizations now tracking and assessing risk with risk-based quality management (RBQM) systems in the wake of new clinical trial designs and the COVDI-19 pandemic? That’s one of the key questions explored during Linda Sullivan’s interv
How can organizations use advanced analytics to complement, enhance, and accelerate current QA practices? That’s one the key questions explored during Linda Sullivan’s interview with Timothé Ménard, Head Quality Data Science & Bioethics Coach i
What’s the best way to develop world-class Quality Assurance (QA) professionals in the clinical trials industry? That’s one of the key questions explored during Linda Sullivan’s interview with David Fryrear, Executive Vice President and Head o
In the final part of our three-part series on the value of Quality Tolerance Limits (QTLs), WCG Senior Advisor Linda Sullivan talks about methods for early detection of risk with Steve Young and Keith Dorricott. Young is the Chief Scientific Of
In the second installment of our three-part series on defining and using Quality Tolerance Limits (QTLs), WCG Senior Advisor Linda Sullivan talks about the process of defining QTLs with Steve Young and Keith Dorricott. Young is the Chief Scient
In the first of this three-part series on defining and using Quality Tolerance Limits (QTLs), WCG Senior Advisor discusses the relationship between QTLs & KRIs with Steve Young and Keith Dorricott. Young is the Chief Scientific Officer at Clu
What’s the current status of diversity efforts in clinical trials given the recent FDA draft guidance and the introduction of the Diverse and Equitable Participation in Clinical Trials (DEPICT) in Congress? That’s the main topic explored during
What are the most important lessons learned by clinical research sites from having to deal with the COVID-19 pandemic the last two years, and what are the challenges these sites face going forward?. That’s the key topic explored during Senior A
What’s the current status of the WCG Avoca Quality Consortium (AQC) — the exciting new collaboration between Metrics Champion Consortium (MCC) and Avoca Quality Consortium, whose mission is to elevate clinical trial quality, drive efficiency,
What are best strategies for utilizing the promise of machine learning, deep learning, and artificial intelligence (AI) in clinical trials? That’s the key topic explored during MCC’s Linda Sullivan’s interview with Jonathan Rowe, Principal at Z
How will the collaboration between Metrics Champion Consortium (MCC) and Avoca Quality Consortium (AQC) help develop new deliverables for the clinical trials industry? That’s the key topic explored during MCC’s Linda Sullivan’s special intervie
What were the top takeaways from the interactive metric sessions led by Keith Dorricott at the recent 4th Annual WCTG/MCC Clinical Trial Risk and Performance Management Virtual Collaborative Summit? That’s the key topic explored during Linda
In Part III of our groundbreaking fabulous four-part series on Viewing Rural Health, Education, and Business Through an Equity Lens, produced in collaboration with Grantmakers in Health, Michelle chats with Kim Davis, Senior Advisor (Home Regio
How can small sponsors develop the right strategies to deal with the challenges of aggregating vital trial data? That’s one of the key topics explored during Linda Sullivan’s interview with Rohit Nambisan and Todd Johnson of Lokavant. The guest
How can sponsors with limited resources be most successful in outsource RBQM? That’s one of the key topics explored during Linda Sullivan’s interview with Liz Wool, founder, and president of the Wool Consulting Group. Wool is a recognized indus
How can organizations best use data to tier sites into groups to support “fit for purpose” risk monitoring? That’s one of the key issues explored during Linda Sullivan’s interview with two CTO guests: Tammy Finnigan, Chief Operating Officer and
Is there a common set of key risk indicators (KRIs) the clinical trials industry is monitoring to achieve world-class Risk-Based Quality Management (RBQM)? That’s one of the key issues explored during Linda Sullivan’s interview with two returni
Centralized monitoring clinical trial programs can catch outlying data points in almost real time and quickly notify the clinical trial study team. That’s one of the key takeaways from Crupa Kurien’s interview with Linda Sullivan, MBA, Executiv
Sponsors should approach Risk-Based Quality Management (RBQM) implementation focusing on supporting some important critical factors, including company culture, trial design, trial operations, as well as continuous improvement. That’s one of the
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us